U-2932（人彌漫大B淋巴瘤細(xì)胞）
-
-
-
-
- +3
英文名稱：U-2932
貨號： CL-0838
價格： ￥1800
U-2932（人彌漫大B淋巴瘤細(xì)胞）
￥1800
套餐組合價
產(chǎn)品信息
| 產(chǎn)品名稱 | U-2932（人彌漫大B淋巴瘤細(xì)胞） |
| 別稱 | U2932 |
| 種屬 | 人 |
| 生長特性 | 懸浮細(xì)胞 |
| 細(xì)胞形態(tài) | 淋巴母細(xì)胞樣，圓形，單個細(xì)胞，少數(shù)聚團(tuán) |
| 凍存條件 |
凍存液：55% 基礎(chǔ)培養(yǎng)基+40% FBS+5% DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長培養(yǎng)基：RPMI-1640+10% FBS+1% P/S 培養(yǎng)條件：氣相：空氣，95%；CO?，5%, 溫度：37℃ |
| 推薦傳代比例 | 1:3-1:4 |
| 推薦換液頻率 | 2-3次/周 |
參考資料(來源文獻(xiàn))
| 背景描述 | established in 1996 from the ascites of a 29-year-old woman with diffuse large B cell lymphoma, who 16 years earlier was diagnosed with advanced stage Hodgkin lymphoma, and relapsed several times after multiple chemo- and radiotharapy regimens to complete remissions; cells were described in the literature to overexpress BCL2, BCL6 and p53; assigned to ABC-like lymphoma subtype (activated B-cell). Exome and RNA sequence data are available (see Ref 18187 and Exome sequence and RNA-Seq). Also, please note: the cell line U-2932 harbours two distinct subpopulations as visible by surface staining of CD19, CD20, and CD38 (see ref 18133); continuous monitoring of subpopulations is advised to prevent accidental loss during passaging. |
| 年齡（性別） | 29Y;Female |
| 組織來源 | 腹水 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 淋巴瘤細(xì)胞 |
| 生物安全等級 | BSL-1 |
位點信息
鑒定圖
-
期刊：ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
影響因子：3.8
引用產(chǎn)品： U-2932 細(xì)胞, OCI-LY-10 細(xì)胞, THP-1 細(xì)胞, OCI-Ly3 細(xì)胞
-
期刊：TOXICOLOGY AND APPLIED PHARMACOLOGY
DOI：10.1016/j.taap.2024.117148
影響因子：3.3
引用產(chǎn)品： OCI-Ly3 細(xì)胞, SU-DHL-4 細(xì)胞, HMy2.CIR 細(xì)胞, WSU-DLCL2 細(xì)胞, U-2932 細(xì)胞
識別碼示意圖
